ISIN | CH0461413939 |
---|---|
Valor Number | 46141393 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom NT GBP |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
Peculiarities |
Current Price * | 141.12 GBP | 06.03.2025 |
---|---|---|
Previous Price * | 141.89 GBP | 05.03.2025 |
52 Week High * | 143.64 GBP | 03.03.2025 |
52 Week Low * | 120.43 GBP | 08.03.2024 |
NAV * | 141.12 GBP | 06.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 132,247,885 | |
Unit/Share Assets *** | 115,869,418 | |
Trading Information SIX |
YTD Performance | +7.19% |
31.12.2024 - 06.03.2025
31.12.2024 06.03.2025 |
---|---|---|
YTD Performance (in CHF) | +7.44% |
31.12.2024 - 06.03.2025
31.12.2024 06.03.2025 |
1 month | +0.45% |
06.02.2025 - 06.03.2025
06.02.2025 06.03.2025 |
3 months | +5.60% |
06.12.2024 - 06.03.2025
06.12.2024 06.03.2025 |
6 months | +7.56% |
06.09.2024 - 06.03.2025
06.09.2024 06.03.2025 |
1 year | +17.25% |
06.03.2024 - 06.03.2025
06.03.2024 06.03.2025 |
2 years | +18.11% |
06.03.2023 - 06.03.2025
06.03.2023 06.03.2025 |
3 years | +40.41% |
07.03.2022 - 06.03.2025
07.03.2022 06.03.2025 |
5 years | +62.77% |
06.03.2020 - 06.03.2025
06.03.2020 06.03.2025 |
Equity Participation Rate in % | 97.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.60% | |
---|---|---|
Shell PLC | 8.13% | |
HSBC Holdings PLC | 7.53% | |
Unilever PLC | 5.62% | |
RELX PLC | 3.67% | |
BP PLC | 3.34% | |
British American Tobacco PLC | 3.11% | |
GSK PLC | 2.85% | |
London Stock Exchange Group PLC | 2.81% | |
Rio Tinto PLC Registered Shares | 2.70% | |
Last data update | 31.01.2025 |
TER | 0.00% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |